A role for the receptor tyrosine kinase Axl in regulating NF-kappa B activity in cutaneous squamous cell carcinomas

A role for the receptor tyrosine kinase Axl in regulating NF-kappa B activity in cutaneous squamous cell carcinomas

Opis bibliograficzny
Główni autorzy:	Papadakis, E, Storey, A, O'Toole, E
Format:	Conference item
Wydane:	2009

Podobne zapisy

A role for the receptor tyrosine kinase, Axl, in cutaneous squamous cell carcinoma survival
od: Papadakis, E, i wsp.
Wydane: (2008)

An antiapoptotic role for the receptor tyrosine kinase Axl in cutaneous squamous cell carcinoma
od: Papadakis, E, i wsp.
Wydane: (2009)

A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival
od: Papadakis, E, i wsp.
Wydane: (2008)

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.
od: Papadakis, E, i wsp.
Wydane: (2011)

The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.
od: Kristine A Drafahl, i wsp.
Wydane: (2010-12-01)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
od: Andrea Pontara, i wsp.
Wydane: (2020-04-01)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
od: Wenchen Zhao, i wsp.
Wydane: (2020-05-01)

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
od: Mohan Shankar Gopinatha Pillai, i wsp.
Wydane: (2023-06-01)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
od: Okimoto RA, i wsp.
Wydane: (2015-04-01)

Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
od: Kristina Breitenecker, i wsp.
Wydane: (2023-09-01)

AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
od: Pardis Mohammadzadeh, i wsp.
Wydane: (2023-10-01)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
od: Edward T Schmid, i wsp.
Wydane: (2016-06-01)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
od: Diana J Uribe, i wsp.
Wydane: (2017-01-01)

Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
od: Alberto Repici, i wsp.
Wydane: (2024-02-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
od: Matthew Walters, i wsp.
Wydane: (2020-11-01)

Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
od: Jeong-Woong Park, i wsp.
Wydane: (2017-10-01)

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
od: Manoj Kumar Kashyap, i wsp.
Wydane: (2018-02-01)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
od: Yeo, Xun Hui, i wsp.
Wydane: (2023)

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
od: Xun Hui Yeo, i wsp.
Wydane: (2023-06-01)

Inhibition of AXL receptor tyrosine kinase enhances brown adipose tissue functionality in mice
od: Vissarion Efthymiou, i wsp.
Wydane: (2023-07-01)

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
od: Lidia Jiménez-García, i wsp.
Wydane: (2022-07-01)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
od: Mariam Fatima, i wsp.
Wydane: (2021-06-01)

NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
od: Smith, C, i wsp.
Wydane: (2001)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma with loss of type VII collagen
od: Martin, V, i wsp.
Wydane: (2008)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
od: Markus Lauter, i wsp.
Wydane: (2019-06-01)

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
od: Pinato, D, i wsp.
Wydane: (2019)

Mechanisms of increased invasion of cutaneous squamous cell carcinoma cells with loss of type VII collagen
od: Martins, V, i wsp.
Wydane: (2009)

Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
od: Liang Gao, i wsp.
Wydane: (2023-08-01)

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
od: Nataliya Pidkovka, i wsp.
Wydane: (2023-07-01)

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.
od: Martins, V, i wsp.
Wydane: (2009)

Exosome‐transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma
od: Qiming Li, i wsp.
Wydane: (2020-09-01)

Correction: Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis
od: Liang Gao, i wsp.
Wydane: (2023-08-01)

Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
od: Xun Hui Yeo, i wsp.
Wydane: (2023-07-01)

Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.
od: Young Sook Kim, i wsp.
Wydane: (2012-01-01)

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
od: Keisuke Iida, i wsp.
Wydane: (2017-12-01)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
od: Pinar Kanlikilicer, i wsp.
Wydane: (2017-12-01)

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
od: Andreakos, E, i wsp.
Wydane: (2006)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
od: Chenjing Zhu, i wsp.
Wydane: (2019-11-01)

Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
od: Robert Torka, i wsp.
Wydane: (2014-04-01)

Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
od: Young H Lee, i wsp.
Wydane: (2021-01-01)